View Press Releases
-
Bio Filters For Air Pollution Control Outlook, Product, Industry Developments and Opportunities
ALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market report
Feb 26, 2020
-
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China
SAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutations
Feb 25, 2020
-
Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Banks intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roches PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors
Feb 25, 2020
-
The Pistoia Alliance’s UDM Project Reaches Major Milestone
BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)
Feb 25, 2020
-
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.
PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc
Feb 25, 2020
-
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies
Feb 24, 2020
-
Streck to present new tube at TRI-CON
LA VISTA, NE - Feb 24, 2020 - Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco
Feb 24, 2020
-
Rare Disease Patient Platform Raremark Partners With TriNetX
CAMBRIDGE, MA - Feb 24, 2020 - TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community
Feb 24, 2020
-
Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis
GLASGOW, SCOTLAND - Feb 24, 2020 - Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETER(TM) wearable biosensor device
Feb 24, 2020
-
Aalto Bio Reagents Launches First Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Protein
DUBLIN, IRELAND - Feb 24, 2020 - Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6404) for diagnostic test manufacturers, vaccine developers and researchers globally
Feb 24, 2020
-
Creative Diagnostics Introduces Innovative Zebrafish Antibodies
SHIRLEY, NY - Feb 25, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches a large range of antibodies against key immune molecules in zebrafish to enhance the research within the fish scientific community as well as mammalian immune disorders researches
Feb 23, 2020
-
Creative Proteomics Released BrdU Cell Proliferation Assay to Be Behind Researchers
SHIRLEY, NY - Feb 21, 2020 - February 21, 2020, since its establishment in 2004, Creative Proteomics has served nearly 2 million researchers from different areas, including clinical, academia and industry
Feb 20, 2020
-
Absolute Antibody Partners with the Technical University of Denmark to Offer Antibodies against Animal Venom Toxins
REDCAR, UK - Feb 20, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms
Feb 20, 2020
-
From Ending Addiction to Preventive Genomics, Bio-IT World 2020 Keynoters Share Data-Driven Approaches
NEEDHAM, MA, UNITED STATES - Feb 19, 2020 - Bio-IT World 2020, the premier conference and expo uniting life science, data science, informatics and IT leaders, today announced its Plenary Keynote sessions
Feb 19, 2020
-
Creative Biolabs Provides Anti-EGFR Therapeutic Antibody---Nimotuzumab for Research Use
SHIRLEY, NY, USE - Feb 19, 2020 - February 19, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody field, announced that the nimotuzumab, a kind of anti-EGFR therapeutic antibody, is now available for research and clinical use
Feb 18, 2020
-
Greenphire and Roche Team to Address Critical Clinical Trial Patient Convenience Issues at 11th Annual SCOPE Summit
ORLANDO, FL, UNITED STATES - Feb 18, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced that it has teamed with top industry sponsor, Roche (SIX: RO, ROG;OTCQX: RHHBY), to address the top hurdles patients face when participating in clinical trials
Feb 18, 2020
-
Signant Health invests for growth with the opening of its new Philadelphia-area office
PHILADELPHIA - Feb 18, 2020 - Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office facility in Blue Bell, Pennsylvania
Feb 18, 2020
-
Optibrium appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development
CAMBRIDGE, UNITED KINGDOM - Feb 18, 2020 - Optibrium, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development
Feb 18, 2020
-
Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor
DURHAM, NC, UNITED STATES - Feb 17, 2020 - For Immediate Release Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor The RTP-based Contract Research Organization will continue to show its support at the charity's 13th annual event in Wake Forest Research Triangle Park, NC ̶ February 17, 2020 ̶ Rho, an RTP-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, today announced it is the 2020 Title Sponsor of the 13th annual Smile Train Triathlon, taking place Sunday, June 28 in Wake Forest, North Carolina
Feb 17, 2020
-
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing
PIOMBINO DESE, PADUA AND INDIANAPOLIS, ITALY - Feb 17, 2020 - Stevanato Group has announced a new partnership with Pfeiffer Vacuum Technologies to provide biopharma companies with advanced Container Closure Integrity (CCI) analysis and testing protocols
Feb 17, 2020